Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Labor Relations and Union-Management Negotiation Experts (US)

Analysis of: Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma (jco.ascopubs.org)
Addition of Zevalin after a CR or PR in low grade, follicular lymphomas adds to CR rates and improves time to progression. The implication is that this will result in improved survivals.
Analysis of: Pharma need not worry too much about President Obama (www.pharmatimes.com)
The implication is that our new chief executive has "bigger fish to fry" than attaching drug costs??
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: Caterpillar/Wal-Mart Rx Drug Pilot Scraps Use of Average Wholesale Price, Uses Drug Cost-Plus Pricing (www.aishealth.com)
A just-published article in Drug Benefit News provides new details about the Wal-Mart’s (WMT) $0 generic co-pay program with Caterpillar (CAT). Anyone involved in the pharmacy channel – pharmacies, pharmacy benefit managers (PBMs), insurers, payers, drug wholesalers – should be paying attention to the...
Analysis of: Glaxo Plans 12% Reduction in Its U.S. Drug Sales Force (online.wsj.com)
"As part of the restructuring, the company plans to group its sales staff around specific treatment areas" including oncology, probably
Analysis of: Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer (www.gene.com)
Genetech is seeking FDA approval for use in the most malignant of brain tumors, Glioblastomas.
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: Walgreen Co. to Acquire Specialty Pharmacy Business from McKesson Corporation (news.walgreens.com)
Walgreens (WAG) announced the acquisition of McKesson’s (MCK) specialty pharmacy business in a win-win transaction for both companies. The deal makes sense for both parties as long you understand that specialty distributors sell products to physicians, providers and pharmacies, while specialty pharmacies...
Adam Fein, PhD, Founder & President
Adam Fein, PhD, Founder & President
Pembroke Consulting Inc
Analysis of: In Sour Economy, Some Scale Back on Medications (www.nytimes.com)
The New York Times ran a story on the impact of the economy on prescriptions. The article provided many compelling personal stories to illustrate data from IMS Health showing a decline in the total number of prescriptions dispensed in the United States. However, I have some concerns about the ability...
Analysis of: Targeting EGFR in Colorectal Cancer (content.nejm.org)
Measuring mutated K-RAS will show who will NOT respond to ImClone's Erbitux or Amgen's Vectibix. Thus to use either in CRC will not be particularly effective.
Richard Block, Professor
Michigan State University
Analysis of: "GM, Chrysler Deal Could Spur UAW Concessions, " Detroit Free Press, October 20, 2008 (www.freep.com)
1.   Broad-based UAW concessions would not be seen by the UAW as addressing the auto industry's problems. 2.   The reductions in hourly employment in the auto industry over the past three years have limited the impact that the UAW has on the auto industry cost structure. 3. The...
Analysis of: Panel Calls for Vaccine for Adult Smokers (online.wsj.com)
31 million more doses of Pneumovax yearly in the US??

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 Next21 to 30 of 672

Analytics


Generated at 2009-01-07T19:00:58.307